Clinical Trial Update: LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis [Phase 2, Phase 3]

View source ↗

Summary

The LCH-IV international collaborative treatment protocol for children and adolescents with Langerhans cell histiocytosis is described, spanning Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Snippet

Sponsor: North American Consortium for Histiocytosis | Conditions: Langerhans Cell Histiocytosis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING